{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:11:26Z","timestamp":1761581486541},"reference-count":13,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Heart J"],"DOI":"10.1093\/eurheartj\/ehw578","type":"journal-article","created":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T12:05:57Z","timestamp":1478865957000},"page":"ehw578","source":"Crossref","is-referenced-by-count":2,"title":["Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium"],"prefix":"10.1093","author":[{"given":"Martin F.","family":"Reiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Breitenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik W.","family":"Holy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Glanzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Amstalden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon F.","family":"St\u00e4mpfli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole R.","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkmar","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Benussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Maisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrg H.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Steffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni G.","family":"Camici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,8]]},"reference":[{"key":"2017010817200700000_ehw578v1.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"2017010817200700000_ehw578v1.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs253"},{"key":"2017010817200700000_ehw578v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68845-4"},{"key":"2017010817200700000_ehw578v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60040-4"},{"key":"2017010817200700000_ehw578v1.5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijcard.2015.03.092","article-title":"Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients","volume":"185","author":"Breitenstein","year":"2015","journal-title":"Int J Cardiol"},{"key":"2017010817200700000_ehw578v1.6","doi-asserted-by":"publisher","DOI":"10.1177\/1074248413511693"},{"key":"2017010817200700000_ehw578v1.7","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/jth.12360","article-title":"Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism","volume":"11","author":"Nylander","year":"2013","journal-title":"J Thromb Haemost: JTH"},{"key":"2017010817200700000_ehw578v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.067"},{"key":"2017010817200700000_ehw578v1.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu298"},{"key":"2017010817200700000_ehw578v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr052"},{"key":"2017010817200700000_ehw578v1.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007432"},{"key":"2017010817200700000_ehw578v1.12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2016.04.008","article-title":"Expression of pro-inflammatory genes in human endothelial cells: comparison of rivaroxaban and dabigatran","volume":"142","author":"Ellinghaus","year":"2016","journal-title":"Thromb Res"},{"key":"2017010817200700000_ehw578v1.13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cct.2015.05.012","article-title":"Rationale and design of the RT-AF study: combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention","volume":"43","author":"Gao","year":"2015","journal-title":"Contemp Clin Trials"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T04:11:13Z","timestamp":1657685473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehw578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,8]]},"references-count":13,"alternative-id":["10.1093\/eurheartj\/ehw578"],"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehw578","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,8]]}}}